Plasmalyte A: Clinical Trials

46 trials of Plasmalyte A, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

24 completed, 10 unknown, 4 terminated, 4 withdrawn. 14 Not applicable, 11 Phase 2, 8 Phase 3, 8 Phase 4, 7 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable14Completed 7, Terminated 2, Unknown 2, Withdrawn 2, Recruiting 1
Phase 211Completed 6, Unknown 2, Withdrawn 2, Active not recruiting 1
Phase 38Completed 5, Terminated 1, Unknown 1, Withdrawn 1
Phase 48Unknown 5, Completed 2, Recruiting 1
Phase 17Completed 4, Active not recruiting 1, Terminated 1, Withdrawn 1
Early Phase 11Completed 1

Follow Plasmalyte A: new trials by email Literature Review of Plasmalyte A trials Research Report on Plasmalyte A

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hypertonic Saline in Posterior Spinal Fusion
Normosol-R, buffered 2% hypertonic saline - Scoliosis Idiopathic, Scoliosis;Congenital
Phase 2 / Phase 3WithdrawnJoseph D. Tobias2025-12-012025-11-10
CReep and Maintenance flUid Sodium Chloride ADministration rEduction in cRitically Ill adultS
Glucose 5% for fluid creep, NaCl 0.9% (normal saline) for fluid creep, PlasmaLyte as maintenance fluid - Critical Care, Intensive Care, Fluid Accumulation
Phase 4RecruitingUniversity Hospital, Antwerp6402025-10-072026-02-03
To Study Effect of Injection Pentoxifylline on Liver Growth After Major Liver Surgery
Pentoxifylline (also known as oxpentifylline), Plasmalyte - Liver Regeneration
Not applicableRecruitingInstitute of Liver and Biliary Sciences, India602025-01-012025-07-25
Evaluation of the Protective Efficacy of TV003 or Previous Zika Infection Against Infection With ZIKV-SJRP Challenge Compared to DENV and ZIKV-naïve Controls Against Infection With ZIKV-SJRP Challenge
TetraVax-DV-TV003 (TV003), Plasmalyte, Challenge virus ZIKV-SJRP/2016-184 - Zika Virus
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)272024-09-242026-03-09
Cartilage Recovery in Adults With Knee Osteorthritis by Mesenchymal Cell Therapy: Randomized Trial of Radiologic and Clinical Outcomes
INMUNOCEM, PLACEBO COMPARATOR - Knee Osteoarthritis
Phase 2UnknownGUSTAVO SALGUERO322023-10-012023-07-07
Efficacy of 5% Albumin v/s Plasmalyte in Combination With 20% Albumin for Fluid Resuscitation in Cirrhosis With Sepsis Induced Hypotension
20% Albumin, 5% Albumin, Plasmalyte - Liver Cirrhosis
Not applicableUnknownInstitute of Liver and Biliary Sciences, India1202023-09-302023-10-10
Crystalloid Fluids and Cardiac Surgery
Normal Saline for fluid resuscitation, PlasmaLyte for fluid resuscitation, Ringer's Lacatate for fluid resusciation - Surgery-Complications
Not applicableWithdrawnCentre hospitalier de l'Université de Montréal (CHUM)2023-03-312025-02-21
Using Vasopressor Medication to Support Blood Pressure During Intubation Procedure
Norepinephrine, Lactated Ringers, Intravenous, normal saline - Respiratory Failure, Hypotension and Shock
Phase 3CompletedWright State University422022-08-092024-07-15
A Study Evaluating the Efficacy and Safety of IV L-Citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury Induced by Cardiopulmonary Bypass in Pediatric Patients Undergoing Surgery for Congenital Heart Defects
L-citrulline, Plasmalyte A - Ventricular Septal Defect, Atrioventricular Septal Defect
Phase 3TerminatedAsklepion Pharmaceuticals, LLC642022-06-292024-09-19
Inflammatory Consequences of Crystalloids in Severely Burned Patients
PlasmaLyte for fluid resuscitation, Ringer's Lactate for fluid resuscitation - Burns
Not applicableTerminatedCentre hospitalier de l'Université de Montréal (CHUM)142021-10-172025-02-21
Hemodynamic Optimization of Cerebral Perfusion After Endovascular Therapy in Patients With Acute Ischemic Stroke
Adjusted medication - Acute Ischemic Stroke
Phase 4UnknownFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau8142021-06-012023-03-16
Balanced Crystalloid Solutions for Acute Pancreatitis
Balanced crystalloid solution, Normal saline - Acute Pancreatitis
Phase 4UnknownUniversity Hospital Rijeka2762020-05-012020-12-30
The Effect of Vitamin D Supplementation on COVID-19 Recovery
Vit-D 0.2 MG/ML Oral Solution [Calcidol], Physiological Irrigating Solution - Covid19
Phase 3CompletedUniversity of Monastir1302020-04-222021-05-12
Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells
Mesenchymal Stem Cells (MSCs), Placebo Infusion (Plasmalyte A with 0.5% human serum albumin) - Diabetes Mellitus, Type 1
Phase 1Active not recruitingMedical University of South Carolina602020-02-272026-04-22
Comparison of Lactated Ringer's Solution and PlasmaLyte-A as a Base Solution for Del Nido Cardioplegia
Lactated Ringer - Myocardial Injury
Not applicableCompletedMahidol University2002019-08-052024-03-15
Balanced Solutions and Plasma Electrolytes
Lactated Ringer's, Normosol - Critical Illness, Acidosis, Metabolic
Not applicableCompletedVanderbilt University Medical Center20932018-06-012019-10-11
Better Evidence for Selecting Transplant Fluids
Plasma-Lyte 148 (approx. pH 7.4) IV Infusion, 0.9% SODIUM CHLORIDE 9g/L injection BP - End Stage Kidney Disease, Delayed Graft Function
Phase 3CompletedThe University of Queensland8082018-01-262024-10-15
Influence of Albumin on Acute Renal Dysfunction Associated With Cardiac Surgery Under Extracorporeal Circulation
Human albumin, Plasmalyte - Acute Kidney Injury
Phase 4UnknownFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau2502018-01-102018-01-25
Fluid Resuscitation in Burn Patients
Plasmalyte, Ringer lactate - Severe Burns, Fluid Resuscitation
Phase 3CompletedAssistance Publique - Hôpitaux de Paris282017-08-092019-12-13
A Low ChloridE hyperTonic Solution for Brain Edema
Sodium chloride /sodium acetate (16.4%), Sodium chloride (23.4%), PlasmaLyte - Subarachnoid Hemorrhage, Acute Kidney Injury
Phase 1CompletedEmory University592017-06-282023-05-01

Showing 20 of 46. Sign in to see all of them.

Conditions studied

Acute Kidney Injury (5)  ·  Acidosis (4)  ·  Critical Illness (4)  ·  Burns (2)  ·  Hyponatremia (2)  ·  Hypotension (2)  ·  Myocardial Infarction (2)  ·  Osteoarthritis (2)  ·  Osteoarthritis, Knee (2)  ·  Shock (2)  ·  Acid-Base Imbalance (1)  ·  Aneurysm (1)  ·  Anterior Wall Myocardial Infarction (1)  ·  Aortic Aneurysm (1)  ·  Aortic Aneurysm, Abdominal (1)

Sponsors

Stempeutics Research Pvt Ltd (5)  ·  Institute of Liver and Biliary Sciences, India (3)  ·  Post Graduate Institute of Medical Education and Research, Chandigarh (3)  ·  Centre hospitalier de l'Université de Montréal (CHUM) (2)  ·  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (2)  ·  Asklepion Pharmaceuticals, LLC (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Austin Health (1)  ·  Brugmann University Hospital (1)  ·  Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1)  ·  Emory University (1)  ·  GUSTAVO SALGUERO (1)  ·  Johns Hopkins University (1)  ·  Joseph D. Tobias (1)  ·  Mahidol University (1)

Countries

United States (14)  ·  India (8)  ·  Canada (6)  ·  Belgium (3)  ·  Australia (2)  ·  Malaysia (2)  ·  Spain (2)  ·  Croatia (1)  ·  France (1)  ·  New Zealand (1)  ·  South Korea (1)  ·  Thailand (1)  ·  Tunisia (1)

Top investigators

Alexandre Joosten, MD (1)  ·  Anna Durbin, M.D. (1)  ·  Bhibas Dasgupta, MS (1)  ·  Brigitte Ickx, Md, Pr (1)  ·  Christopher Mastropietro, MD, FCCM (1)  ·  Dato' Dr. Ramli Baba, MS (1)  ·  Dr Abdul Syukur Abdullah, MD (1)  ·  Dr Abhinav Verma, MD (1)  ·  Dr Chuah Siew Kee, MD (1)  ·  Dr Dato K Chandran, MD (1)  ·  Dr Irene Looi, MD (1)  ·  Dr Uduman Ali Mohamed Yousuf, MD (1)  ·  Dr Yau Weng Keong, MD (1)

Results publications

PMID 10102718, PMID 11046201, PMID 12243433, PMID 15115561, PMID 15591303, PMID 16537374, PMID 18666740, PMID 19115651, PMID 21037437, PMID 21705897, PMID 22816029, PMID 23073953, PMID 23325915, PMID 23732264, PMID 23758736, PMID 24253140, PMID 24415398, PMID 24891325, PMID 25472864, PMID 25484310, PMID 25593740, PMID 26123384, PMID 27749094, PMID 27993154, PMID 30428930, PMID 30455077, PMID 32391156, PMID 32450917, PMID 33974564, PMID 34315432, PMID 35042554, PMID 35460725, PMID 36803273, PMID 37343576, PMID 38244592, PMID 39208776, PMID 39971001, PMID 401925, PMID 42003602, PMID 42258192, PMID 8161863

NIH funding

2008 (1), 2025 (1), 5UM1HL087318 (1), R01DK118529 (1), U01HL108713 (1)